Sumatriptan's Effect on Synaptic Transmission in the Rat Midbrain
Author Information
Author(s): Jeong Hyo-Jin, Chenu David, Johnson Emma E, Connor Mark, Vaughan Christopher W
Primary Institution: Pain Management Research Institute, Kolling Institute of Medical Research, Northern Clinical School, The University of Sydney at Royal North Shore Hospital
Hypothesis
The study examines the serotonergic modulation of GABAergic and glutamatergic synaptic transmission in rat midbrain PAG slices.
Conclusion
Sumatriptan inhibits GABAergic and glutamatergic synaptic transmission within the PAG via a 5-HT1B/D receptor mediated reduction in neurotransmitter release.
Supporting Evidence
- 5-HT and sumatriptan reduced the amplitude of evoked GABAA mediated IPSCs.
- The inhibition of evoked IPSCs produced by 5-HT was concentration dependent.
- Sumatriptan also inhibited evoked EPSCs with a significant reduction in amplitude.
- Functional 5-HT1A, 5-HT1B, and 5-HT1D receptors were present on GABAergic nerve terminals within the PAG.
Takeaway
This study shows that a migraine medicine called sumatriptan can help reduce signals in the brain that cause pain by affecting how certain brain cells communicate.
Methodology
The study used male and female Sprague-Dawley rats to examine synaptic transmission in midbrain PAG slices through electrophysiological recordings.
Participant Demographics
Male and female Sprague-Dawley rats, aged 16-28 days.
Statistical Information
P-Value
p < 0.0001
Confidence Interval
90% CI = 75 – 273 nM for 5-HT, 90% CI = 42 – 1,610 nM for sumatriptan
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website